Stay updated on TGRX-326 Chinese Phase I Clinical Trial
Sign up to get notified when there's something new on the TGRX-326 Chinese Phase I Clinical Trial page.

Latest updates to the TGRX-326 Chinese Phase I Clinical Trial page
- Check4 days agoChange DetectedThe history adds a recruitment status change to not recruiting participants and records a new revision v3.6.0, while removing the prior revision v3.5.5.SummaryDifference0.4%

- Check11 days agoChange DetectedAdded a new revision entry: v3.5.5, replacing the previous v3.5.4 in the record history. This reflects an update to the page history rather than substantive content changes.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision entry, v3.5.4, has been added to the Study Record Versions, replacing the previous v3.5.3 in the history. This indicates an updated revision entry on the page reflecting a newer version of the study record.SummaryDifference0.1%

- Check54 days agoChange DetectedThis updates the displayed application/version revision for the ClinicalTrials.gov page from v3.5.2 to v3.5.3 without altering the study record’s content. The record history list of submissions remains the same.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check83 days agoChange DetectedSponsor entity updated from Shenzhen TargetRx, Inc. to Shenzhen TargetRx Co., Ltd.SummaryDifference0.2%

Stay in the know with updates to TGRX-326 Chinese Phase I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TGRX-326 Chinese Phase I Clinical Trial page.